We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.7B
AUM Growth
-$514M
(-1.2%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,385
New
223
Increased
794
Reduced
1,083
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$348M |
| 2 |
LyondellBasell Industries
LYB
|
+$251M |
| 3 |
Pfizer
PFE
|
+$244M |
| 4 |
Fidelity National Information Services
FIS
|
+$179M |
| 5 |
Amcor
AMCR
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$427M |
| 2 |
Kimberly-Clark
KMB
|
+$279M |
| 3 |
Procter & Gamble
PG
|
+$253M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$194M |
| 5 |
General Mills
GIS
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.96% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Halliburton
HAL
$29.2B
| $65K | ﹤0.01% |
3,446
-8,972
| -72% | -$186K |
|
|
OPI
1702
DELISTED
Office Properties Income Trust
OPI
| $61K | ﹤0.01% |
2,001
+153
| +8% | +$4.27K |
|
1703
Dianthus Therapeutics
DNTH
$5.83B
| $60K | ﹤0.01% |
365
+133
| +57% | +$25.3K |
|
1704
Precision BioSciences
DTIL
$183M
| $59K | ﹤0.01% |
+234
| New | +$76.2K |
|
1705
Arcus Biosciences
RCUS
$3.16B
| $59K | ﹤0.01% |
6,505
-82
| -1% | -$659 |
|
1706
LCI Industries
LCII
$2.16B
| $58K | ﹤0.01% |
628
+48
| +8% | +$4.27K |
|
1707
Nelnet
NNI
$4.56B
| $58K | ﹤0.01% |
917
+356
| +63% | +$22.8K |
|
1708
SiriusXM
SIRI
$9.86B
| $58K | ﹤0.01% |
+930
| New | +$57.2K |
|
1709
CVR Energy
CVI
$5.35B
| $57K | ﹤0.01% |
1,287
+99
| +8% | +$4.61K |
|
1710
Equifax
EFX
$19.4B
| $57K | ﹤0.01% |
402
+22
| +6% | +$3.1K |
|
|
SNR
1711
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $57K | ﹤0.01% |
8,599
+657
| +8% | +$4.36K |
|
|
MNTA
1712
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $57K | ﹤0.01% |
4,396
+336
| +8% | +$4.06K |
|
1713
Coty
COTY
$2.33B
| $56K | ﹤0.01% |
5,375
-441,153
| -99% | -$4.57M |
|
1714
CorVel
CRVL
$3.58B
| $56K | ﹤0.01% |
2,232
+12
| +0.5% | +$341 |
|
|
MANT
1715
DELISTED
Mantech International Corp
MANT
| $56K | ﹤0.01% |
785
+60
| +8% | +$4.1K |
|
1716
ArcBest
ARCB
$2.9B
| $55K | ﹤0.01% |
1,817
+60
| +3% | +$1.73K |
|
1717
WesBanco
WSBC
$3.83B
| $54K | ﹤0.01% |
1,436
+873
| +155% | +$31.6K |
|
|
AFI
1718
DELISTED
Armstrong Flooring, Inc.
AFI
| $54K | ﹤0.01% |
8,444
+6,439
| +321% | +$50.3K |
|
|
MTSC
1719
DELISTED
MTS Systems Corp
MTSC
| $53K | ﹤0.01% |
960
-1,519
| -61% | -$86.8K |
|
1720
1-800-Flowers.com
FLWS
$180M
| $52K | ﹤0.01% |
3,485
-1,462
| -30% | -$25.3K |
|
1721
W&T Offshore
WTI
$593M
| $52K | ﹤0.01% |
11,838
-21,783
| -65% | -$99.6K |
|
1722
CytomX Therapeutics
CTMX
$617M
| $51K | ﹤0.01% |
+6,970
| New | +$68.8K |
|
1723
CareTrust REIT
CTRE
$9.04B
| $51K | ﹤0.01% |
2,177
+166
| +8% | +$3.9K |
|
|
ARD
1724
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $51K | ﹤0.01% |
3,248
-209,637
| -98% | -$3.6M |
|
|
ACHN
1725
DELISTED
Achillion Pharmaceuticals
ACHN
| $51K | ﹤0.01% |
14,259
-4,460
| -24% | -$17.2K |
|
Similar funds
Federated Hermes's Q3 2019 Portfolio in Review
As of Q3 2019, Federated Hermes held 2,385 positions worth $40.7B, down 1.2% from $41.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Federated Hermes's Q3 2019 filing shows 223 new, 794 increased, 1,083 reduced and 195 closed positions. Its largest new stake was Medallia, Inc.: 852,063 shares worth $23.4M. The largest sale was Crown Castle, an estimated $427M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2019 buy was Medallia, Inc.: 852,063 shares worth $23.4M.
- Federated Hermes added most to Gilead Sciences in Q3 2019, an estimated $348M increase.
- Federated Hermes's biggest Q3 2019 reduction was Crown Castle, cutting an estimated $427M.
- Federated Hermes fully exited Worldpay, Inc. in Q3 2019, selling an estimated $194M.
- Federated Hermes's ten largest holdings make up 17% of its $40.7B portfolio in Q3 2019.
- Federated Hermes opened 223 new positions and closed 195 in Q3 2019.
- Federated Hermes's portfolio value fell 1.2% quarter-over-quarter to $40.7B.
Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.